PT81427B - 3,4-diazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel - Google Patents

3,4-diazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Info

Publication number
PT81427B
PT81427B PT81427A PT8142785A PT81427B PT 81427 B PT81427 B PT 81427B PT 81427 A PT81427 A PT 81427A PT 8142785 A PT8142785 A PT 8142785A PT 81427 B PT81427 B PT 81427B
Authority
PT
Portugal
Prior art keywords
compounds
production
compositions containing
derivatives method
diazol
Prior art date
Application number
PT81427A
Other languages
German (de)
English (en)
Other versions
PT81427A (de
Original Assignee
Heumann Ludwig & Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Ludwig & Co Gmbh filed Critical Heumann Ludwig & Co Gmbh
Publication of PT81427A publication Critical patent/PT81427A/pt
Publication of PT81427B publication Critical patent/PT81427B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
PT81427A 1984-11-09 1985-11-04 3,4-diazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel PT81427B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843441086 DE3441086A1 (de) 1984-11-09 1984-11-09 3,4-diazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
PT81427A PT81427A (de) 1985-12-01
PT81427B true PT81427B (de) 1987-04-09

Family

ID=6249961

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81427A PT81427B (de) 1984-11-09 1985-11-04 3,4-diazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Country Status (15)

Country Link
US (1) US4727081A (pt)
EP (1) EP0180754A3 (pt)
JP (1) JPS61115074A (pt)
KR (1) KR860004040A (pt)
AU (1) AU575441B2 (pt)
DE (1) DE3441086A1 (pt)
DK (1) DK512185A (pt)
ES (4) ES8609315A1 (pt)
GR (1) GR852687B (pt)
HU (1) HU194197B (pt)
IL (1) IL76818A (pt)
NZ (1) NZ214097A (pt)
PT (1) PT81427B (pt)
YU (1) YU173585A (pt)
ZA (1) ZA858194B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3513184A1 (de) * 1985-04-12 1986-10-16 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CN101863852B (zh) * 2010-06-29 2011-09-21 沈阳航空航天大学 含1,3,4-噁二唑杂环结构芳香二元胺及其制备方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA815964B (en) * 1980-08-27 1983-04-27 Glaxo Group Ltd Heterocyclic derivatives
JPS59196879A (ja) * 1983-04-08 1984-11-08 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体

Also Published As

Publication number Publication date
EP0180754A2 (de) 1986-05-14
HUT40427A (en) 1986-12-28
ES548289A0 (es) 1986-09-01
ES554601A0 (es) 1987-04-16
ES8704488A1 (es) 1987-04-16
ES554602A0 (es) 1987-04-16
HU194197B (en) 1988-01-28
US4727081A (en) 1988-02-23
EP0180754A3 (de) 1987-02-25
IL76818A0 (en) 1986-02-28
KR860004040A (ko) 1986-06-16
ZA858194B (en) 1986-06-25
DK512185D0 (da) 1985-11-06
GR852687B (pt) 1986-03-11
ES8704489A1 (es) 1987-04-16
IL76818A (en) 1990-06-10
AU575441B2 (en) 1988-07-28
ES554603A0 (es) 1987-04-16
ES8609315A1 (es) 1986-09-01
DE3441086A1 (de) 1986-05-15
AU4933385A (en) 1986-05-15
ES8704487A1 (es) 1987-04-16
YU173585A (en) 1988-04-30
DK512185A (da) 1986-05-10
PT81427A (de) 1985-12-01
JPS61115074A (ja) 1986-06-02
NZ214097A (en) 1988-08-30

Similar Documents

Publication Publication Date Title
PT80476A (de) Neue aminotetralinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT80425A (de) Neue pyrrolo-benzimidazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE58904674D1 (de) 4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt.
PT82789A (de) Neue 2-arylmidazole diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ATE63903T1 (de) 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
DE3575724D1 (de) Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE60760T1 (de) N-benzoylharnstoffverbindungen, diese enthaltende antitumorzusammensetzungen und verfahren zu deren herstellung.
PT85335A (de) Neue benzolsulfonamido-indanylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT86227A (de) Neue heteroaromatische aminderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3579436D1 (de) Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen.
DE3484048D1 (de) Phenylethylamine, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3579000D1 (de) Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
PT80484B (de) Neue benzazepinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3588039D1 (de) Azetidinonderivate und Verfahren zu ihrer Herstellung.
DE3577199D1 (de) Semicarbazidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3580133D1 (de) N-benzoyl-n'-pyridazinyloxyphenyl harnstoff-verbindungen, diese enthaltende antitumor-zusammensetzungen und verfahren zu deren herstellung.
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3789466D1 (de) 3,7-Disubstituierte-3-Cephemverbindungen und Verfahren zu ihrer Herstellung.
DE3583780D1 (de) 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT85639A (de) Neue sulfonamido-athylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung